Showing results (1261-1270 of 2,709) with videos related to

Sort By:
Pageof 271
The Lancet. Infectious Diseases|April 13, 2024
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trialHong-Xing Pan, Ling-Xian Qiu, Qi Liang, et al.
The Lancet. Infectious Diseases|April 25, 2024
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in ChinaWenting Zuo, Di He, Chaoyang Liang, et al.
The Lancet. Infectious Diseases|January 25, 2026
Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled studyThomas Louie, Wendy Ribble, Louis Boccumini, et al.
The Lancet. Infectious Diseases|January 15, 2026
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational studyJosefina L Razzini, Iago Giné-Vázquez, Jing Jin, et al.
The Lancet. Infectious Diseases|November 28, 2025
Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in LeukaemiaDina Averbuch, Yuri Vanbiervliet, Francesco Baccelli, et al.
The Lancet. Infectious Diseases|December 1, 2025
Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysisIsobel McLachlan, Chris Robertson, Kirsty E Morrison, et al.
The Lancet. Infectious Diseases|December 4, 2025
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trialGeorg M N Behrens, Lambert Assoumou, Geoffroy Liegeon, et al.
The Lancet. Infectious Diseases|December 24, 2024
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trialRichard Idro, Thandile Nkosi-Gondwe, Robert Opoka, et al.
The Lancet. Infectious Diseases|December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysisJulia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 271